Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients - Wikidata - awgldk - TriplyDB

Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients

Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients

http://www.wikidata.org/entity/Q35683762

about

Prevalence and clinical impact of magnesium disorders in end-stage renal disease: a protocol for a systematic review Magnesium in CKD: more than a calcification inhibitor?Lack of influence of serum magnesium levels on overall mortality and cardiovascular outcomes in patients with advanced chronic kidney disease.The role of serum magnesium and calcium on the association between adiponectin levels and all-cause mortality in end-stage renal disease patients.Magnesium basics Serum magnesium concentrations in patients receiving sodium picosulfate and magnesium citrate bowel preparation: an assessment of renal function and electrocardiographic conduction.Proton pump inhibitors use in hemodialysis patients and serum magnesium levels Association Between the Use of Proton Pump Inhibitors and the Risk of ESRD in Renal Diseases: A Population-Based, Case-Control Study.Magnesium and osteoporosis: current state of knowledge and future research directions.The relationship between elevated magnesium levels and coronary artery ectasia Magnesium and cardiovascular complications of chronic kidney disease.Pathophysiology of Calcium, Phosphorus, and Magnesium Dysregulation in Chronic Kidney Disease.Clinical aspects of magnesium physiology in patients on dialysis.Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients.Ionized and total serum magnesium in hemodialysis: predictors and variability. A longitudinal cross-sectional study.The Divalent Elements Changes in Early Stages of Chronic Kidney Disease.Magnesium and Risk of Hip Fracture among Patients Undergoing Hemodialysis.Proton-pump inhibitors do not influence serum magnesium levels in renal transplant recipients.Magnesium supplementation: A consideration in dialysis patients.Morphological and clinical findings in Sri Lankan patients with chronic kidney disease of unknown cause (CKDu): Similarities and differences with Mesoamerican Nephropathy.Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.Magnesium and Human Health: Perspectives and Research Directions.Serum Magnesium after Kidney Transplantation: A Systematic Review.Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD).

P2860

Q26999603-9EA7E741-AAC7-4EBD-8356-DF5B037A5D8B Q27027086-F7671A41-0F86-40E7-8C30-433267E199A1 Q33710843-88BBDC8A-B8D1-4BDE-BC3C-ACD70FF4475A Q34533678-06BC2DC7-AC49-4CF0-8DED-482087B42FCA Q35683770-0F2DDE0C-7E43-4F12-B0D6-B47DDEC763C0 Q35914404-4FCE60E4-7204-4B46-B768-F1B4483FE4C6 Q36493276-D55BC983-3A21-4B0E-8498-6D8D22A59EBD Q36822474-DB1F9085-E61B-4160-9BE9-F6FC74858A2A Q37177394-EDE385C1-B702-462E-A6C4-FC97C895F964 Q37726034-BE64DC4F-E2FF-4CA6-8146-6488657465AF Q38473932-2E16EE87-3158-430C-8C18-68ABB8EAF501 Q38572880-F816B133-759B-4DF8-BAAF-9ACA841C9FB7 Q39369171-DF80F195-3107-43D7-85F2-519704BB21F4 Q39558547-0D2C3964-7CE6-46D1-BDB3-317EE9D15F81 Q47584614-15206754-169C-43C7-9DE3-8FCA7CBBA0E0 Q47760167-D7BBE86B-97F4-40FC-889C-90FE40734783 Q48207264-34F66335-6758-4297-94D6-08C151B9C617 Q49070652-A2029A41-63A4-4E8E-AFF4-50B5230C7B39 Q50074589-99DCF93E-CDD9-4B2F-AB14-D52BC8D0CFB7 Q52669450-8E6672E7-8C12-470E-92B5-BA9A6710F39D Q55385149-66B4775C-7F1C-411E-BB1F-9D24CF97CC82 Q55396565-F6236302-5A3B-49BE-ADFD-BF1989F5AF20 Q55447877-48E2D9B9-6187-4078-8591-FFBF50C44EBA Q55476982-E10C1F71-DF85-4CE5-98E8-B8961971EF8B

P2860

Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients

http://www.wikidata.org/entity/Q35683762

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients

@ast

Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients

@en

type

label

Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients

@ast

Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients

@en

prefLabel

Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients

@ast

Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients

@en

P1433

Q35683762-1ACAB451-0A13-4EFB-A642-44675C2780CF

P1476

Q35683762-C15CE1D0-FD76-4E3D-8F25-5E011392FCC2

P2093

Q35683762-259F7A18-CE64-4C74-B969-6B411CF29B65

Q35683762-5A0D0874-EC5B-4FC2-AF3F-42F7C285ABC8

P2860

Q35683762-0057CA31-E227-4BF0-B2C2-4A77ED173FDC

Q35683762-00C30149-A45F-4048-8A83-D0A5A1343DA3

Q35683762-08196306-DEE9-4652-BCDD-B4F20B3305FC

Q35683762-0EF5DBBC-8BCF-468E-AD1A-C1D231FC8837

Q35683762-10D057FE-1B1D-40E7-BFC0-26480D69E1A1

Q35683762-1265B28C-1E23-45B8-8A36-F0858A06D4E9

Q35683762-207A6ED1-BF01-4351-AE41-F4CEDA748E2A

Q35683762-225B6348-3722-4E60-B7BC-1EA684DE500E

Q35683762-227B2759-C75B-494F-A5FB-F7ECA1933624

Q35683762-2292F5A2-9CCB-429C-A54D-DECE5E13C75D

P304

Q35683762-C90BE7CB-B339-4272-88D5-D48B4E5ABA85

P31

Q35683762-E7CF707F-8055-4A80-979F-F85885033DDA

P356

Q35683762-CB846FBB-EEA9-4D64-A296-C12763F5E891

P433

Q35683762-B16C23DF-7054-43AB-80FC-498F3D61F638

P478

Q35683762-D8262842-B139-4A28-AB7B-33CD67D46407

P50

Q35683762-6B000A1B-5387-4169-8978-B98E983A1792

P577

Q35683762-38C34ABD-8DB8-4A83-94C9-4DA03D30489B

P5875

Q35683762-BABA8639-A2F0-492E-ABF1-6E03D8652B67

P698

Q35683762-C1A234A3-F74A-43B1-ACF9-0AC6DA3009C1

P921

Q35683762-CE41746C-49C5-447C-9E7B-1BCC62393E6A

Q35683762-f4202cfc-ac6e-4e5b-996e-db88107087a5

P932

Q35683762-81970CFA-1C53-42BC-BC22-20B7A6503854

P356

P1433

Clinical kidney journal / an academic journal of the ERA-EDTA (European Renal Association - European Dialysis and Transplant Association)

P1476

Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients

@en

P2093

John Cunningham

http://www.w3.org/2001/XMLSchema#string

Piergiorgio Messa

http://www.w3.org/2001/XMLSchema#string

P2860

Skeletal and hormonal effects of magnesium deficiency

Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid

Paradoxical block of parathormone secretion is mediated by increased activity of G alpha subunits.

Intestinal absorption of magnesium from food and supplements.

Bone magnesium pools in uremia

Magnesium and the parathyroid.

Magnesium basics

Regulation of magnesium balance: lessons learned from human genetic disease

The five most commonly used intact parathyroid hormone assays are useful for screening but not for diagnosing bone turnover abnormalities in CKD-5 patients

Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate

P304

i39-i51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDTPLUS/SFR166

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Mariano Rodríguez

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275116111

http://www.w3.org/2001/XMLSchema#string

P698

26069820

http://www.w3.org/2001/XMLSchema#string

P921

Béésh Łikoní

P932

4455820

http://www.w3.org/2001/XMLSchema#string